These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 33466352)
1. Classification of Congeneric and QSAR of Homologous Antileukemic Castellano G; León A; Torrens F Molecules; 2021 Jan; 26(1):. PubMed ID: 33466352 [TBL] [Abstract][Full Text] [Related]
2. Cysteine chloromethyl and diazomethyl ketone derivatives with potent anti-leukemic activity. Perrey DA; Narla RK; Uckun FM Bioorg Med Chem Lett; 2000 Mar; 10(6):547-9. PubMed ID: 10741550 [TBL] [Abstract][Full Text] [Related]
3. Organic phenyl arsonic acid compounds with potent antileukemic activity. Liu XP; Narla RK; Uckun FM Bioorg Med Chem Lett; 2003 Feb; 13(3):581-3. PubMed ID: 12565976 [TBL] [Abstract][Full Text] [Related]
4. The S-alkyl chain length as a determinant of the anti-leukemic activity of cysteine chloromethyl ketone compounds. Perrey DA; Scannell MP; Narla RK; Uckun FM Bioorg Med Chem Lett; 2000 Mar; 10(6):551-2. PubMed ID: 10741551 [TBL] [Abstract][Full Text] [Related]
5. A degradation study of a series of chloromethyl and diazomethyl ketone anti-leukemic agents. Kotchevar AT; Perrey DA; Uckun FM Drug Dev Ind Pharm; 2002; 28(2):143-9. PubMed ID: 11926358 [TBL] [Abstract][Full Text] [Related]
6. Carbonyl-substituted titanocenes: a novel class of cytostatic compounds with high antitumor and antileukemic activity. Gansäuer A; Winkler I; Worgull D; Lauterbach T; Franke D; Selig A; Wagner L; Prokop A Chemistry; 2008; 14(14):4160-3. PubMed ID: 18384037 [No Abstract] [Full Text] [Related]
7. Design and synthesis of various quinizarin derivatives as potential anticancer agents in acute T lymphoblastic leukemia. Hu X; Cao Y; Yin X; Zhu L; Chen Y; Wang W; Hu J Bioorg Med Chem; 2019 Apr; 27(7):1362-1369. PubMed ID: 30827866 [TBL] [Abstract][Full Text] [Related]
8. Antitumor agents: diazomethyl ketone and chloromethyl ketone analogues prepared from N-tosyl amino acids. Sajadi Z; Kashani M; Loeffler LJ; Hall IH J Med Chem; 1980 Mar; 23(3):275-8. PubMed ID: 7365742 [TBL] [Abstract][Full Text] [Related]
9. Bortezomib interferes with adhesion of B cell precursor acute lymphoblastic leukemia cells through SPARC up-regulation in human bone marrow mesenchymal stromal/stem cells. Iwasa M; Miura Y; Fujishiro A; Fujii S; Sugino N; Yoshioka S; Yokota A; Hishita T; Hirai H; Andoh A; Ichinohe T; Maekawa T Int J Hematol; 2017 May; 105(5):587-597. PubMed ID: 28044259 [TBL] [Abstract][Full Text] [Related]
10. De novo purine synthesis inhibition and antileukemic effects of mercaptopurine alone or in combination with methotrexate in vivo. Dervieux T; Brenner TL; Hon YY; Zhou Y; Hancock ML; Sandlund JT; Rivera GK; Ribeiro RC; Boyett JM; Pui CH; Relling MV; Evans WE Blood; 2002 Aug; 100(4):1240-7. PubMed ID: 12149204 [TBL] [Abstract][Full Text] [Related]
11. N-(1'-naphthyl)-3,4,5-trimethoxybenzohydrazide as microtubule destabilizer: Synthesis, cytotoxicity, inhibition of cell migration and in vivo activity against acute lymphoblastic leukemia. Salum LB; Mascarello A; Canevarolo RR; Altei WF; Laranjeira AB; Neuenfeldt PD; Stumpf TR; Chiaradia-Delatorre LD; Vollmer LL; Daghestani HN; de Souza Melo CP; Silveira AB; Leal PC; Frederico MJ; do Nascimento LF; Santos AR; Andricopulo AD; Day BW; Yunes RA; Vogt A; Yunes JA; Nunes RJ Eur J Med Chem; 2015; 96():504-18. PubMed ID: 25951294 [TBL] [Abstract][Full Text] [Related]
12. Analogues of the cytostatic and antimitogenic agents chlamydocin and HC-toxin: synthesis and biological activity of chloromethyl ketone and diazomethyl ketone functionalized cyclic tetrapeptides. Shute RE; Dunlap B; Rich DH J Med Chem; 1987 Jan; 30(1):71-8. PubMed ID: 3806605 [TBL] [Abstract][Full Text] [Related]
13. Novel Conjugated Unsaturated Ketones with Submicromolar Potencies Towards some Leukemic and Colon Cancer Cells. Das S; Gul HI; Das U; Balzarini J; Dimmock SG; Dimmock JR Med Chem; 2019; 15(4):430-438. PubMed ID: 30324886 [TBL] [Abstract][Full Text] [Related]
14. Structure-based design of specific inhibitors of Janus kinase 3 as apoptosis-inducing antileukemic agents. Sudbeck EA; Liu XP; Narla RK; Mahajan S; Ghosh S; Mao C; Uckun FM Clin Cancer Res; 1999 Jun; 5(6):1569-82. PubMed ID: 10389946 [TBL] [Abstract][Full Text] [Related]
15. N-(4-Hydroxylphenyl)retinamide (fenretinide, 4-HPR), a retinoid compound with antileukemic and proapoptotic activity in acute lymphoblastic leukemia (ALL). Faderl S; Lotan R; Kantarjian HM; Harris D; Van Q; Estrov Z Leuk Res; 2003 Mar; 27(3):259-66. PubMed ID: 12537979 [TBL] [Abstract][Full Text] [Related]
16. 3D-QSAR and docking studies on ursolic acid derivatives for anticancer activity based on bladder cell line T24 targeting NF-kB pathway inhibition. Yadav D; Nath Mishra B; Khan F J Biomol Struct Dyn; 2019 Sep; 37(14):3822-3837. PubMed ID: 30261824 [TBL] [Abstract][Full Text] [Related]
17. Application of GA-MLR for QSAR Modeling of the Arylthioindole Class of Tubulin Polymerization Inhibitors as Anticancer Agents. Ahmadi S; Habibpour E Anticancer Agents Med Chem; 2017; 17(4):552-565. PubMed ID: 27528182 [TBL] [Abstract][Full Text] [Related]
18. A QSAR analysis of 2-phenoxy-N-substituted acetamide analogues as hypoxia-inducible factor-1(HIF-1) inhibitors: a rational approach to anticancer drug design. Noolvi MN; Patel HM; Kamboj S Med Chem; 2012 Jul; 8(4):599-614. PubMed ID: 22530909 [TBL] [Abstract][Full Text] [Related]
19. Quantitative structure-antitumor activity relationships of camptothecin analogues: cluster analysis and genetic algorithm-based studies. Fan Y; Shi LM; Kohn KW; Pommier Y; Weinstein JN J Med Chem; 2001 Sep; 44(20):3254-63. PubMed ID: 11563924 [TBL] [Abstract][Full Text] [Related]
20. KML001 and doxercalciferol induce synergistic antileukemic effect in acute lymphoid leukemia cells. Liu Y; Shin DY; Oh S; Kim S; Koh Y; Kim I Oncol Rep; 2017 Jul; 38(1):481-487. PubMed ID: 28586017 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]